Program Perspectives in Cell- and Gene-Based Medicines - DGTI

More documents

Recommendations

Info

Poster Exhibition P3.11 Molecular Basis of Retroviral Integration Clusters Carolin Preiss, Frankfurt P3.12 Response of Hematopoietic Cells to the Activation of Evi1 Olga S. Kustikova, Hannover P4 Modulating Vector Cell Interactions P4.01 Prototype Foamy Virus Pseudotransduction for Transient and Targeted RNA Transfer Martin Hamann, Dresden P4.02 Reduced Sensitivity Of Measles Virus Glycoprotein Based Lentiviral Targeting Vectors Towards Neutralizing Antibodies Sabrina Kneissl, Langen P4.03 Doxycycline-regulated expression of cytidine deaminase (CDD) mediates myeloprotection and avoids lymphotoxicity in a murine transplant model Nico Lachmann, Hannover P4.04 MicroRNA-150-regulated Vectors Allow Lymphocyte-sparing Transgene Expression In Hematopoietic Gene Therapy Sebastian Brennig, Hannover P4.05 Complete tropism restriction by display of high affinity ligands on adeno-associated viral vectors Robert Münch, Langen P4.06 A second generation lentiviral vector targeting system displays targeting ligands on a type I transmembrane protein Anke Rasbach, Langen P4.07 Development of AAV2-based vector for tissue engineering Jessica Sallach, Cologne P4.08 The regulation of 5-lipoxygenase by microRNAs Saskia Busch, Frankfurt P4.09 Self-complementary AAV vector systems for highly regulated expression of interfering RNA (RNAi) molecules Regine Heilbronn, Berlin P4.10 Development of Safety Improved Lentiviral Vectors Containing Ubiquitous Chromatin Opening Elements Uta Müller-Kuller, Frankfurt P4.11 Methylation of L1Hs promoters is lower on the inactive X, has a tendency of being higher on autosomes in smaller genomes and shows inter-individual variability at some loci Heike Singer, Bonn 32
P4.12 Hypoxia-induced alternative splicing in endothelial cells Julia Weigand, Frankfurt P4.13 Small molecule dependent ribozymes for conditional gene expression and the controlled release of antagomir RNA Alexander Wittmann, Frankfurt P4.14 In vivo imaging of regulated transgene expression in mice and rat brain Andrea Maddalena, Göttingen P5 Genetic, Metabolic and Acquired Disorders P5.01 Age-dependent upregulation of miR-34a controls cardiac apoptosis and function Reinier Boon, Frankfurt P5.02 Calcium Phosphate Nanoparticles: A new Tool for the Transfection of Corneal Endothelial Cells Thomas Fuchsluger, Duesseldorf P5.03 Polymer Coating of Adenoviral Vectors for Effective Systemic Gene Delivery Using the Sodium Iodide Symporter (NIS) as Reporter and Therapy Gene Geoffrey Grünwald, Munich P5.04 Safety And Efficacy Of A Gene Transfer Strategy To Bypass Factor VIII Using Factor IX Variants Peter Milanov, Dresden P5.05 Canalostomy as a surgical approach for cochlear gene therapy in the rat Davina Gassner, Frankfurt P5.06 Development Of K562 Cell Lines Expressing The Fya- And Fyb-Duffy Blood-group Antigen For Studies On The Binding Preferences To Certain Plasmodium Vivax Strains Peter Milanov, Dresden P5.07 Development of a gene trap gene therapy approach enabling the inducible expansion of genetically modified hematopoietic precursor cells Carolin Nowak, Frankfurt P5.08 Comparison Of Chitosan-Based Antisense Oligonucleotide And Sirna For Gene Silencing Suna Ozbas Turan, Istanbul P5.09 Overcoming the paucity of primary XCGD patient cells for research Shweta Pahujani, Frankfurt 33
Page 1 and 2: Perspectives in Cell- and Gene-Base
Page 3 and 4: List of Contents Welcome Adresses 4
Page 5 and 6: Welcome Dear participants, ladies a
Page 7 and 8: General Information Organizers •
Page 9 and 10: Venue University Campus Westend Hö
Page 11 and 12: Non-Smoking Congress The Conference
Page 13 and 14: Information for the Poster Exhibiti
Page 15 and 16: Saturday HZ 8 HZ 11 HZ 2 8:30-10:30
Page 17 and 18: Thursday, March 15 Plenary Session
Page 19 and 20: Friday, March 16 09:30 - 10:00 Auto
Page 21 and 22: Friday, March 16 Inv24 11:40 - 12:0
Page 23 and 24: Friday, March 16 Or6.5 15:48 - 16:0
Page 25 and 26: Friday, March 16 The Regulation of
Page 27 and 28: Poster Exhibition Poster view with
Page 29 and 30: P2a.16 Modeling RUNX1 biallelic mut
Page 31: P3 Clonality in Normal and Aberrant
Page 35 and 36: P6 Regenerative Medicine P6.01 Gene
Page 37 and 38: P7.07 Activation of allogeneic NK c
Page 39 and 40: Surname First name Organisation Bre
Page 41 and 42: Surname First name Organisation Ham
Page 43 and 44: Surname First name Organisation Loc
Page 45 and 46: Surname First name Organisation Sal
Page 47 and 48: Surname First name Organisation von
Page 49 and 50: Exhibition Plan 1st Floor 118 110 1
Page 51 and 52: Directions Campus Westend Philipp-H
Page 53 and 54: Notes 53
Page 55 and 56: Essential Resources in Celland Gene

Program Perspectives in Cell- and Gene-Based Medicines - DGTI

Create successful ePaper yourself

Delete template?

Save as template?